Our findings identify AA as a potent modulator of Ca<sup>2+</sup> and redox signalling in lung fibroblasts, and highlight GPR40, TRPV4, IP<sub>3</sub>Rs and lysosomal TPCs as potential therapeutic targets for intervening in pulmonary fibrosis. Here, FFAR1 is linked to pulmonary fibrosis.